Bristol Myers Squibb reported $18.99B in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
ALKERMES ALKS:US $ 383.44M 17.6M
Amgen AMGN:US $ 14585M 1716M
AstraZeneca AZN:LN 22222M 709M
Astrazeneca AZN:US $ 22222M 709M
Biogen BIIB:US $ 3347.2M 181.4M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Catalent CTLT:US $ 1196M 56.8M
Coherus Biosciences CHRS:US $ 287.05M 29.45M
Drreddys Laboratories RDY:US $ 91525M 8134M
Eli Lilly And LLY:US $ 15093.2M 3379M
Endo International Ordinary Shares ENDP:US $ 1409.21M 13.72M
Gilead Sciences GILD:US $ 10214M 509M
GlaxoSmithKline GSK:LN 21387M 1112M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Horizon Pharma HZNP:US $ 852.81M 78.97M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
JAZZ PHA JAZZ:US $ 880.59M 128.5M
Lannett LCI:US $ 90.47M 6.66M
Medtronic MDT:US $ 7764M 745M
Novartis NOVN:VX SF 29633M 527M
Perrigo Ordinary Shares PRGO:US $ 1984.5M 537.7M
Phibro Animal Health PAHC:US $ 164.12M 4.78M
Prestige Brands PBH:US $ 125.05M 2.91M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Revance Therapeutics RVNC:US $ 58.25M 7.41M
Teva Pharmaceutical Industries TEVA:US $ 12691M 602M
United Therapeutics UTHR:US $ 311.4M 9M
Zoetis ZTS:US $ 2091M 25M